Fate Therapeutics In
FATE
Delayed Nasdaq - 08/18 09:59:59 pm
2.88USD
-4.64%
Upcoming events

- No events available -

Past Events
08/16/17 | 07:20pmWedbush PacGrow Health Care Conference
08/14/17 | 11:00pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
08/03/17Wells Fargo San Francisco Biotech Corporate Access Day
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
4,40
4,34
1,5%

3,91
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-32,0
-33,4
4,4%

-41,2
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-33,5
-35,0
4,5%

-41,6
Net income
Million $
Released
Forecast
Spread
-33,5
-35,1
4,7%

-41,7
EPS
 $
Released
Forecast
Spread
-1,05
-1,14
8,1%

-0,99
Announcement Date03/16/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
1,03
0,94
9,5%

0,93
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-9,57
-9,99
4,2%

-10,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-9,65
-10,1
4,5%

-10,5
Net income
Million $
Released
Forecast
Spread
-9,65
-10,1
4,4%

-10,5
EPS
 $
Released
Forecast
Spread
-0,23
-0,24
4,2%

-0,25
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise